Stocks and Investing Stocks and Investing
Thu, February 29, 2024

Bill Sutherland Maintained (AGL) at Strong Buy with Decreased Target to $9 on, Feb 29th, 2024


Published on 2024-10-28 09:20:48 - WOPRAI, Bill Sutherland
  Print publication without navigation


Bill Sutherland of Benchmark, Maintained "agilon health, inc." (AGL) at Strong Buy with Decreased Target from $13 to $9 on, Feb 29th, 2024.

Bill has made no other calls on AGL in the last 4 months.



There are 10 other peers that have a rating on AGL. Out of the 10 peers that are also analyzing AGL, 7 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Elizabeth Anderson of "Evercore ISI Group" Maintained at Hold with Decreased Target to $6 on, Wednesday, February 28th, 2024
  • Gary Taylor of "TD Cowen" Downgraded from Buy to Hold and Decreased Target to $6.5 on, Monday, February 26th, 2024
  • Craig Jones of "Stifel" Maintained at Hold with Decreased Target to $9 on, Thursday, February 22nd, 2024
  • Justin Lake of "Wolfe Research" Downgraded from Buy to Hold on, Monday, January 8th, 2024
  • Lisa Gill of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $9 on, Friday, January 5th, 2024
  • Jamie Perse of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Monday, December 11th, 2023
  • George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $12 on, Tuesday, November 21st, 2023


These are the ratings of the 3 analyists that currently disagree with Bill


  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Wednesday, February 28th, 2024
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $8 on, Monday, February 26th, 2024
  • Constantine Davides of "JMP Securities" Initiated at Buy and Held Target at $18 on, Wednesday, December 6th, 2023
Contributing Sources